Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false
creator	label
publisher	pref label
tabling member	label

Search

1121842

	human indexable
	published
	registered interest
	answer date	24/04/2019
	date	18/04/2019
	date tabled	18/04/2019
	ddp created	18/04/2019 15:17:54
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	18/04/2019 15:46:32 30/04/2019 16:49:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	245751
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	30/04/2019 16:17:46
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure adequate supplies of treatments for (a) epilepsy and (b) bipolar disorder in all scenarios surrounding the UK's exit from the EU.
	session	2017/19
	session number	1
	tabling member constituency	Eastbourne
	tabling member printed	Stephen Lloyd
	title	House of Commons Tabled Parliamentary Question 2017/19 245751
	type	WrittenParliamentaryQuestion
	uin	245751
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	3968 label Biography information for Stephen Lloyd
	publisher	25259 pref label House of Commons
	tabling member	3968 label Biography information for Stephen Lloyd

867296

	human indexable
	published
	registered interest
	answer date	20/03/2018
	date	20/03/2018
	date tabled	20/03/2018
	ddp created	20/03/2018 13:15:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	20/03/2018 13:25:06 20/03/2018 18:03:03
	hansard heading	Bowel Cancer: Screening
	house id	1
	identifier	904478
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	20/03/2018 17:31:43
	question text	What the timetable is for the implementation of the faecal immunochemical test for bowel cancer screening.
	session	2017/19
	session number	1
	tabling member constituency	Eastbourne
	tabling member printed	Stephen Lloyd
	title	House of Commons Tabled Parliamentary Question 2017/19 904478
	type	WrittenParliamentaryQuestion
	uin	904478
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	3968 label Biography information for Stephen Lloyd
	publisher	25259 pref label House of Commons
	tabling member	3968 label Biography information for Stephen Lloyd

852660

	human indexable
	published
	registered interest
	answer date	05/03/2018
	date	01/03/2018
	date tabled	01/03/2018
	ddp created	01/03/2018 17:19:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/03/2018 13:55:36 08/03/2018 15:39:05
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	identifier	130656
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	08/03/2018 15:07:27
	question text	To ask the Secretary of State for Health and Social Care, if officials of his Department will meet patient organisations to ensure the patient voice is heard during the re-negotiation of the Pharmaceutical Price Regulation Scheme.
	session	2017/19
	session number	1
	tabling member constituency	Eastbourne
	tabling member printed	Stephen Lloyd
	title	House of Commons Tabled Parliamentary Question 2017/19 130656
	type	WrittenParliamentaryQuestion
	uin	130656
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	3968 label Biography information for Stephen Lloyd
	publisher	25259 pref label House of Commons
	tabling member	3968 label Biography information for Stephen Lloyd

852696

	human indexable
	published
	registered interest
	answer date	05/03/2018
	date	01/03/2018
	date tabled	01/03/2018
	ddp created	01/03/2018 17:20:40
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/03/2018 13:55:39 08/03/2018 15:37:04
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	identifier	130691
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	08/03/2018 15:05:20
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 December 2017 to Question 115087 on Pharmaceutical Price Regulation Scheme, whether a decision has been made on the timing of negotiations with industry on the next Pharmaceutical Price Regulation Scheme.
	session	2017/19
	session number	1
	tabling member constituency	Eastbourne
	tabling member printed	Stephen Lloyd
	title	House of Commons Tabled Parliamentary Question 2017/19 130691
	type	WrittenParliamentaryQuestion
	uin	130691
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	3968 label Biography information for Stephen Lloyd
	publisher	25259 pref label House of Commons
	tabling member	3968 label Biography information for Stephen Lloyd

847777

	human indexable
	published
	registered interest
	answer date	27/02/2018
	date	23/02/2018
	date tabled	23/02/2018
	ddp created	23/02/2018 16:03:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/02/2018 16:07:29 05/03/2018 16:20:07
	hansard heading	Bowel Cancer: Screening
	house id	1
	identifier	129453
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	05/03/2018 15:49:09
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the new faecal immunochemical test will be introduced in April 2018 as planned.
	session	2017/19
	session number	1
	tabling member constituency	Eastbourne
	tabling member printed	Stephen Lloyd
	title	House of Commons Tabled Parliamentary Question 2017/19 129453
	type	WrittenParliamentaryQuestion
	uin	129453
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	3968 label Biography information for Stephen Lloyd
	publisher	25259 pref label House of Commons
	tabling member	3968 label Biography information for Stephen Lloyd

847778

	human indexable
	published
	registered interest
	answer date	27/02/2018
	date	23/02/2018
	date tabled	23/02/2018
	ddp created	23/02/2018 16:03:39
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/02/2018 16:07:30 05/03/2018 16:20:06
	hansard heading	Bowel Cancer: Screening
	house id	1
	identifier	129454
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	05/03/2018 15:49:09
	question text	To ask the Secretary of State for Health and Social Care, which health body will be responsible for making the final decision on the sensitivity threshold for the faecal immunochemical test when it is introduced into the bowel cancer screening programme due to be implemented in April 2018.
	session	2017/19
	session number	1
	tabling member constituency	Eastbourne
	tabling member printed	Stephen Lloyd
	title	House of Commons Tabled Parliamentary Question 2017/19 129454
	type	WrittenParliamentaryQuestion
	uin	129454
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	3968 label Biography information for Stephen Lloyd
	publisher	25259 pref label House of Commons
	tabling member	3968 label Biography information for Stephen Lloyd

846998

	human indexable
	published
	registered interest
	answer date	26/02/2018
	date	22/02/2018
	date tabled	22/02/2018
	ddp created	22/02/2018 19:50:51
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	22/02/2018 20:01:23 28/02/2018 15:17:03
	hansard heading	Bowel Cancer: Screening
	house id	1
	identifier	129172
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	28/02/2018 14:45:19
	question text	To ask the Secretary of State for Health and Social Care, whether a decision has been reached on the sensitivity threshold for the faecal immunochemical test when it is introduced into the bowel cancer screening programme due to be implemented in April 2018; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	Eastbourne
	tabling member printed	Stephen Lloyd
	title	House of Commons Tabled Parliamentary Question 2017/19 129172
	type	WrittenParliamentaryQuestion
	uin	129172
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	3968 label Biography information for Stephen Lloyd
	publisher	25259 pref label House of Commons
	tabling member	3968 label Biography information for Stephen Lloyd